Table 1.
Clinical characteristics of control and EOP sample population.
| Case | GA (weeks) | PNA (days) | PMI (h) | Gender | Postmortem diagnosis |
|---|---|---|---|---|---|
| 1 | 20 | 0 | N/A | N/A | Stillborn |
| 2 | 20 | 0 | 6 | M | Stillborn |
| 3 | 22 | 0 | 8 | F | Chorioamnionitis |
| 4 | 24 | 0 | 11 | F | Extreme prematurity |
| 5 | 26 | 2 | 22 | M | Prematurity/sepsis |
| 6 | 27 | 1 | 18 | M | Stillborn/Renal agenesis |
| 7 | 30 | 0 | 12 | F | Stillborn |
| 8 | 33 | 1 | N/A | F | CHD |
| 9 | 35 | 2 | 19 | M | Stillborn/Renal agenesis |
| 10 | 36 | 0 | N/A | M | Stillborn |
| 11 | 36 | 0 | 21 | F | Stillborn/Umbilical cord abnormality |
| 12 | 37 | 0 | 20 | M | Stillborn/chorioamnionitis |
| 13 | 37 | 2 | 17 | M | CHD |
| 14 | 39 | 0 | 11 | F | Placental abruption |
| 15 | 39 | 0 | 19 | F | Positional asphyxia |
| 16 | 23 | 0 | 12 | F | EOP, Pulmonary hypoplasia |
| 17 | 26 | 2 | 10 | M | EOP, Pneumonia |
| 18 | 28 | 5 | 13 | M | EOP, Hypoplastic left heart syndrome |
| 19 | 32 | 2 | 20 | F | EOP, Necrotizing enterocolitis |
| 20 | 34 | 3 | 21 | F | EOP, Hypoplastic left heart syndrome |
| 21 | 35 | 1 | 14 | F | EOP, MCA |
| 22 | 36 | 0 | 17 | M | EOP, CHD |
| 23 | 38 | 2 | 9 | M | EOP, Sepsis |
| 24 | 39 | 0 | 11 | M | EOP, Pulmonary hypoplasia |
| 25 | 39 | 3 | 12 | F | EOP, Hypoplastic left heart syndrome |
| 26 | 39 | 3 | 12 | M | EOP, CHD |
| 27 | N/A | 47 years | 17 | M | Trauma |
| 28 | N/A | 55 years | 24 | F | Aortic aneurism |
| 29 | N/A | 58 years | 22 | F | Trauma |
| 30 | N/A | 60 years | 11 | M | Pulmonary embolism |
Legend: CHD, congenital heart disease/defect; EOP, encephalopathy of prematurity; F, female; GA, gestational age; GM, germinal matrix; M, male; N/A, information not available; PMI, postmortem interval; PNA, postnatal age; MCA, multiple congenital abnormalities.